Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma
โ Scribed by Masahiro Kanayama; Hidenari Nagai; Yasukiyo Sumino
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 310 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND. Approximately 25% of patients with metastatic breast carcinoma develop hepatic involvement during the course of their disease that further affects their survival. Systemic paclitaxel is safe and has demonstrated good antitumor activity against breast carcinoma. The objec
## Background: The long term efficacy of combination therapy with transcatheter arterial embolization (tae) followed by percutaneous ethanol injection (pei) was studied in patients with large primary hepatocellular carcinoma (hcc) tumors and cirrhosis. ## Methods: The series included 83 patients